M
Manuel Monreal
Researcher at Autonomous University of Barcelona
Publications - 499
Citations - 23299
Manuel Monreal is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Pulmonary embolism & Medicine. The author has an hindex of 66, co-authored 437 publications receiving 18821 citations. Previous affiliations of Manuel Monreal include Carlos III Health Institute & Universidad Católica San Antonio de Murcia.
Papers
More filters
Journal ArticleDOI
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Behnood Bikdeli,Mahesh V. Madhavan,David Jiménez,Taylor Chuich,Isaac Dreyfus,Elissa Driggin,Caroline Der Nigoghossian,Walter Ageno,Mohammad Madjid,Yutao Guo,Liang V. Tang,Yu Hu,Jay Giri,Mary Cushman,Isabelle Quéré,Evangelos Dimakakos,C. Michael Gibson,C. Michael Gibson,Giuseppe Lippi,Emmanuel J. Favaloro,Jawed Fareed,Joseph A. Caprini,Alfonso Tafur,John R. Burton,Dominic P. Francese,Elizabeth Y. Wang,Anna Falanga,Claire McLintock,Beverley J. Hunt,Alex C. Spyropoulos,Geoffrey D. Barnes,John W. Eikelboom,John W. Eikelboom,Ido Weinberg,Sam Schulman,Marc Carrier,Gregory Piazza,Gregory Piazza,Joshua A. Beckman,P. Gabriel Steg,Gregg W. Stone,Stephan Rosenkranz,Samuel Z. Goldhaber,Samuel Z. Goldhaber,Sahil A. Parikh,Manuel Monreal,Harlan M. Krumholz,Stavros Konstantinides,Jeffrey I. Weitz,Gregory Y.H. Lip,Gregory Y.H. Lip +50 more
TL;DR: The current understanding of the pathogenesis, epidemiology, management and outcomes of patients with COVID-19 who develop venous or arterial thrombosis, and of those with preexistingThrombotic disease who develop CO VID-19 are reviewed.
Journal ArticleDOI
Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism.
David Jiménez,Drahomir Aujesky,Lisa K. Moores,Vicente Clemente Gómez,José Luis Lobo,Fernando Uresandi,Remedios Otero,Manuel Monreal,Alfonso Muriel,Roger D. Yusen +9 more
TL;DR: The simplified PESI has similar prognostic accuracy and clinical utility and greater ease of use compared with the original PESi and is applicable to outpatients with acute pulmonary embolism.
Journal ArticleDOI
Low-molecular-weight heparin in the treatment of patients with venous thromboembolism
JW tenCate,H. R. Büller,Michael Gent,Jack Hirsh,Martin H. Prins,R. Baildon,Awa Lensing,Anderson,Ejr vanBeek,JN Fiesinger,Jgp Tijssen,A vanBarneveld,LT Eimers,YP Graafsma,Rohan J. K. Hettiarachchi,Barbara A. Hutten,K Redekop,Susan Haley,L LIberale,Terri Finch,S Whittaker,L Wilkinson,Paolo Prandoni,Sabina Villalta,B Girolami,P Bagatella,L Rossi,Antonio Girolami,Franco Piovella,M Barone,C Beltrametti,S Serafini,Sergio Siragusa,E Ascari,Michael J. Kovacs,Beverly Morrow,Judy Kovacs,Pmm Kuijer,Mmw Koopman,H Jagt,J. I. Weitz,Clive Kearon,L Biagioni,Sylvia Haas,F Lossner,FA Spengel,M Berger,Christine Demers,J Poulin,J vanderMeer,Gth Que,WM Smid,KS Robinson,Eleanor Boyle,[No Value] Leclerc,B StJacques,S Finkenbine,Alexander Gallus,D Cohlan,C Rich,D. P. M. Brandjes,CA Hoefnagel,M deRijk,F. Turkstra,Louis Desjardins,J CoteDesjardins,L Couture,M Ruel,J Villenueve,William Geerts,Richard M. Jay,Eki Code,Agg Turpie,Judith Johnson,P Nguyen,[No Value] Cusson,S Roy,P. S. Wells,Janis Bormanis,D Goudie,Moira Cruickshank,M vonLewinski,Manuel Monreal,JC Sahuquillo,E Lafoz,G Simonneau,F Parent,J Jagot,James D. Douketis,Krystyna Kinnon,Jeffrey S. Ginsberg,Patrick Brill-Edwards,Dianne Donovan,Paul Ockelford,Jareer Kassis,S Bornais,B Planchon,D ElKouri,MA Pistorius,M Escribano,G Garrido,C N Chesterman,Beng H. Chong,S Pritchard,John Cade,T Bynon,J Stanford,WM Brien,B Palmer,R Faivre,B Petiteau,PM Manucci,Marco Moia,Paolo Bucciarelli +113 more
TL;DR: Fixed-dose, subcutaneous low-molecular-weight heparin is as effective and safe as adjusted- dose, intravenous unfractionated Heparin for the initial management of venous thromboembolism, regardless of whether the patient has pulmonary embolism or a history of venOUS thrombolism.
Journal ArticleDOI
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge,Philippe Debourdeau,M Beckers,C. Baglin,Rupert Bauersachs,Barry M. Brenner,Dialina Brilhante,Anna Falanga,G T Gerotzafias,Nissim Haim,Ajay K. Kakkar,Alok A. Khorana,Ramón Lecumberri,Mario Mandalà,Michel Marty,Manuel Monreal,Shaker A. Mousa,Simon Noble,Ingrid Pabinger,Paolo Prandoni,Martin H. Prins,Mohammed H. Qari,Michael B. Streiff,Konstantinos N. Syrigos,Henri Bounameaux,H. R. Büller +25 more
TL;DR: The use of LMWH for VTE prevention in cancer patients undergoing laparoscopic surgery may be recommended as for laparotomy and mechanical methods are not recommended as monotherapy except when pharmacological methods are contraindicated.
Journal ArticleDOI
Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry.
Silvy Laporte,Patrick Mismetti,Hervé Decousus,Fernando Uresandi,Remedios Otero,José Luis Lobo,Manuel Monreal +6 more
TL;DR: The clinical predictors identified in the present study should be included in any clinical risk stratification scheme to optimally adapt the treatment of PE to the risk of the fatal outcome.